Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 235

1.

Modelling measles re-emergence as a result of waning of immunity in vaccinated populations.

Mossong J, Muller CP.

Vaccine. 2003 Nov 7;21(31):4597-603.

PMID:
14575773
2.

Measles epidemic in Romania, 1996-1998: assessment of vaccine effectiveness by case-control and cohort studies.

Hennessey KA, Ion-Nedelcu N, Craciun MD, Toma F, Wattigney W, Strebel PM.

Am J Epidemiol. 1999 Dec 1;150(11):1250-7.

PMID:
10588086
3.

Modeling the impact of subclinical measles transmission in vaccinated populations with waning immunity.

Mossong J, Nokes DJ, Edmunds WJ, Cox MJ, Ratnam S, Muller CP.

Am J Epidemiol. 1999 Dec 1;150(11):1238-49.

PMID:
10588085
4.

Waning of vaccine-induced immunity: is it a problem in Africa?

Aaby P, Cisse B, Simondon F, Samb B, Soumaré M, Whittle H.

Am J Epidemiol. 1999 Feb 15;149(4):304-5.

PMID:
10025471
5.

Estimation of the time-dependent vaccine efficacy from a measles epidemic.

Eichner M, Diebner HH, Schubert C, Kreth HW, Dietz K.

Stat Med. 2002 Aug 30;21(16):2355-68.

PMID:
12210620
6.

Measles serological survey in the Italian population: interpretation of results using mixture model.

Rota MC, Massari M, Gabutti G, Guido M, De Donno A, Ciofi degli Atti ML.

Vaccine. 2008 Aug 12;26(34):4403-9. doi: 10.1016/j.vaccine.2008.05.094.

PMID:
18585420
7.

Measles vaccine efficacy during an epidemic in 1998 in the highly vaccinated population of Poland.

Janaszek W, Gay NJ, Gut W.

Vaccine. 2003 Jan 17;21(5-6):473-8.

PMID:
12531646
8.

Population immunity to measles in the United States, 1999.

Hutchins SS, Bellini WJ, Coronado V, Jiles R, Wooten K, Deladisma A.

J Infect Dis. 2004 May 1;189 Suppl 1:S91-7. Review.

9.

Modelling antibody response to measles vaccine and subsequent waning of immunity in a low exposure population.

Mossong J, O'Callaghan CJ, Ratnam S.

Vaccine. 2000 Oct 15;19(4-5):523-9.

PMID:
11027817
10.

Waning immunity and subclinical measles infections in England.

Glass K, Grenfell BT.

Vaccine. 2004 Sep 28;22(29-30):4110-6.

PMID:
15364464
11.

Immunity against measles in populations of women and infants in Poland.

Janaszek W, Slusarczyk J.

Vaccine. 2003 Jun 20;21(21-22):2948-53.

PMID:
12798638
12.
13.

Measles epidemic in the Netherlands, 1999-2000.

van den Hof S, Conyn-van Spaendonck MA, van Steenbergen JE.

J Infect Dis. 2002 Nov 15;186(10):1483-6.

14.

Measles vaccine effectiveness and duration of vaccine-induced immunity in the absence of boosting from exposure to measles virus.

Güriş D, McCready J, Watson JC, Atkinson WL, Heath JL, Bellini WJ, Polloi A.

Pediatr Infect Dis J. 1996 Dec;15(12):1082-6.

PMID:
8970216
15.
16.

Predicted impact of the HIV-1 epidemic on measles in developing countries: results from a dynamic age-structured model.

Scott S, Mossong J, Moss WJ, Cutts FT, Cousens S.

Int J Epidemiol. 2008 Apr;37(2):356-67. doi: 10.1093/ije/dyn007.

17.

Measles in the 1980s.

Christopher PJ, MacDonald PA, Murphy AM, Buckley PR.

Med J Aust. 1983 Nov 12;2(10):488-91.

PMID:
6633361
18.

Measles antibody levels in a vaccinated population in Brazil.

Cox MJ, Azevedo RS, Massad E, Fooks AR, Nokes DJ.

Trans R Soc Trop Med Hyg. 1998 Mar-Apr;92(2):227-30.

PMID:
9764341
19.

Vaccination levels associated with lack of measles transmission among preschool-aged populations in the United States, 1989-1991.

Hutchins SS, Baughman AL, Orr M, Haley C, Hadler S.

J Infect Dis. 2004 May 1;189 Suppl 1:S108-15.

20.

One dose of varicella vaccine does not prevent school outbreaks: is it time for a second dose?

Lopez AS, Guris D, Zimmerman L, Gladden L, Moore T, Haselow DT, Loparev VN, Schmid DS, Jumaan AO, Snow SL.

Pediatrics. 2006 Jun;117(6):e1070-7.

PMID:
16740809
Items per page

Supplemental Content

Support Center